- Abstract:
-
Objective
We aimed to characterise the effects of CYP2B6 polymorphisms, diurnal variation, and demographic factors on nevirapine pharmacokinetics in African children.
Methods
Nonlinear mixed-effects modelling conducted in NONMEM 7.3 described nevirapine plasma concentration-time data from 414 children aged 0.3–15 years.
Results
Nevirapine pharmacokinetics was best described using a 1-compartmental disposition model with elimination through a well-...
Expand abstract - Publication status:
- Published
- Peer review status:
- Peer reviewed
- Version:
- Publisher's version
- Grant:
- 2004.01.H.d2.33011
- Publisher:
- Oxford University Press Publisher's website
- Journal:
- Journal of Antimicrobial Chemotherapy Journal website
- Volume:
- 72
- Issue:
- 1
- Pages:
- 190–199
- Publication date:
- 2016-10-05
- Acceptance date:
- 2016-08-18
- DOI:
- EISSN:
-
1460-2091
- ISSN:
-
0305-7453
- Pubs id:
-
pubs:639002
- URN:
-
uri:99a80c6d-5ee8-468f-b1d5-cf33b95fda37
- UUID:
-
99a80c6d-5ee8-468f-b1d5-cf33b95fda37
- Local pid:
- pubs:639002
- Copyright holder:
- Walker et al
- Copyright date:
- 2016
- Notes:
- © The Author 2016. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
Journal article
The effect of diurnal variation, CYP2B6 genotype, and age on the pharmacokinetics of nevirapine in African Children
Actions
Authors
Funding
+ European and Developing Countries Clinical Trials Partnership
More from this funder
Medical Research Council
More from this funder
Department for International Development
More from this funder
Ministerio de Sanidad y Consumo Spain
More from this funder
Expand funders...
Bibliographic Details
Item Description
Terms of use
Metrics
Altmetrics
Dimensions
If you are the owner of this record, you can report an update to it here: Report update to this record